TFGT
HBIO icon

TS Financial Group (TSFG)’s Harvard Bioscience HBIO Stock Holding History

TS Financial Group (TSFG)’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30
Closed – – 858
2025
Q2 		$0 Hold
30
– – ﹤0.01% 836
2025
Q1 		$0 Hold
30
– – ﹤0.01% 825
2024
Q4 		$1K Hold
30
– – ﹤0.01% 704
2024
Q3 		$1K Hold
30
– – ﹤0.01% 732
2024
Q2 		$1K Hold
30
– – ﹤0.01% 724
2024
Q1 		$1K Hold
30
– – ﹤0.01% 721
2023
Q4 		$2K Hold
30
– – ﹤0.01% 730
2023
Q3 		$1K Hold
30
– – ﹤0.01% 950
2023
Q2 		$2K Hold
30
– – ﹤0.01% 828
2023
Q1 		$1K Sell
30
-20
-40% -$593 ﹤0.01% 897
2022
Q4 		$1K Hold
50
– – ﹤0.01% 914
2022
Q3 		$1K Hold
50
– – ﹤0.01% 887
2022
Q2 		$2K Hold
50
– – ﹤0.01% 797
2022
Q1 		$3K Hold
50
– – ﹤0.01% 714
2021
Q4 		$4K Hold
50
– – ﹤0.01% 685
2021
Q3 		$3K Hold
50
– – ﹤0.01% 704
2021
Q2 		$4K Buy
50
+20
+67% +$1.42K ﹤0.01% 672
2021
Q1 		$2K Hold
30
– – ﹤0.01% 677
2020
Q4 		$1K Hold
30
– – ﹤0.01% 839
2020
Q3 		$1K Hold
30
– – ﹤0.01% 756
2020
Q2 		$1K Hold
30
– – ﹤0.01% 758
2020
Q1 		$1K Hold
30
– – ﹤0.01% 710
2019
Q4 		$1K Hold
30
– – ﹤0.01% 728
2019
Q3 		$1K Hold
30
– – ﹤0.01% 720
2019
Q2 		$1K Hold
30
– – ﹤0.01% 695
2019
Q1 		$1K Buy
+30
New +$1.09K ﹤0.01% 684

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TS Financial Group (TSFG)'s HBIO Position: Q3 2025 in Review

TS Financial Group (TSFG) sold out of Harvard Bioscience (HBIO) in Q3 2025, closing a stake of 30 shares.

TS Financial Group (TSFG) first reported a position in HBIO in Q1 2019 and held it in 26 quarters. The position peaked at $4K in Q4 2021. 59 funds tracked by Wall St. Rank hold HBIO as of Q3 2025.

  • TS Financial Group (TSFG) reported no remaining Harvard Bioscience position as of Q3 2025 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 30 Harvard Bioscience shares in Q3 2025.
  • TS Financial Group (TSFG) first reported a position in Harvard Bioscience in Q1 2019 and held it in 26 quarters.
  • TS Financial Group (TSFG)'s Harvard Bioscience position peaked at $4K in Q4 2021.
  • 59 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2025.

Based on TS Financial Group (TSFG)'s 13F filing for Q3 2025, filed 4 Nov 2025.